Healthcare / Medical DistributionKuala Lumpur
$0.26
+0.01 (+4.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 14%
FCF escenarios
weak_data · normalized FCF $-26.7M · quality 28.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
29/100
D
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.7B
P/E
26.0x
↑EV/EBITDA
11.0x
↓ROE
11.2%
↑Gross Margin
10.4%
↓Debt/Equity
1.89
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+4.1%
FCF CAGR
—
FCF margin
-1.4%
FCF / Net income
-1.16x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $3.93B · net income $48.5M · FCF $-56.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.93B | $3.93B | $3.76B | $3.40B | $3.48B |
| Net Income | $48.5M | $48.5M | $131.8M | $-80.2M | $-629.9M |
| EBITDA | $136.1M | $136.1M | $266.1M | $-16.3M | $-570.5M |
| EPS | 0.01 | 0.01 | 0.05 | -0.03 | -0.29 |
| Gross Margin | 10.4% | 10.4% | 14.4% | 9.0% | -6.0% |
| Operating Margin | 3.3% | 3.3% | 6.9% | -0.6% | -15.1% |
| Net Margin | 1.2% | 1.2% | 3.5% | -2.4% | -18.1% |
| Balance Sheet | |||||
| Debt/Equity | 1.89 | 1.89 | -6.96 | -3.98 | -3.16 |
| Current Ratio | 0.92 | 0.92 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-56.4M | $-56.4M | $3.1M | $-26.7M | $-220.0M |
| Returns | |||||
| ROE | 11.2% | 11.2% | -77.0% | 26.8% | 170.4% |
| Valuation | |||||
| P/E | 26.00 | 26.00 | 6.34 | — | — |
| EV/EBITDA | 11.03 | 11.03 | 7.12 | — | — |
| P/B | 2.16 | 2.16 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 4.5% | 4.5% | 10.4% | -2.2% | — |
| EPS Growth | -75.4% | -75.4% | 256.1% | 87.8% | — |
| Dividend Yield | 1.0% | 1.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
19.9%
EPS terminal req.
$0.02
Spread vs growth
-95.2%
5Y implied EPS CAGR
15.8%
EPS terminal req.
$0.03
Spread vs growth
-91.2%
10Y implied EPS CAGR
12.9%
EPS terminal req.
$0.04
Spread vs growth
-88.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-6.2%
Start / end P/E
5.1x → 19.4x
EPS bridge
0.05 → 0.01
Residual
-208.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.